Co-Diagnostics, Inc. to Present at the Lytham Partners Virtual Investor Conference on November 30, 2017 at 2:00 p.m. ET
Management to Review Investor Presentation and Conduct Q&A;Replay Available on Demand
|Event:||Lytham Partners Virtual Investor Conference|
|Date:||November 30, 2017|
2:00 p.m. ET / 11:00 a.m. PT
http://ir.codiagnostics.com/events-and-presentations or http://www.lythampartners.com/vic.aspx, or by accessing the link here.
Interested parties around the world may view the live investor presentation and ask the speakers questions in real time.
A replay of the presentation will be available on demand following the conclusion of the live event at http://ir.codiagnostics.com/events-and-presentations or http://www.lythampartners.com/vic.aspx, or by accessing the link here.
With the exception of historical information, the content in this
press release and the virtual investor conference referred to in this
communication, may contain “forward looking statements” that are made
pursuant to the Safe Harbor Provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements can be
identified by words such as “believes,” “expects,” “estimates,”
“intends,” “may,” “plans,” “will” and similar expressions, or the
negative of these words. Such forward-looking statements are based on
facts and conditions as they exist at the time such statements are made
and predictions as to future facts and conditions. These statements are
based on management’s current expectations and are subject to
uncertainty and changes in circumstances. Investors are cautioned that
forward-looking statements involve risks and uncertainties that could
cause actual results to differ materially from the statements made.
Readers of this press release are cautioned not to place undue reliance
on any forward-looking statements. Risks, uncertainties and other
factors are discussed in the Company’s filings with the U.S. Securities
and Exchange Commission on Annual
Andrew Benson, Investor Relations
Joe Diaz, Robert Blum, Joe Dorame